Sandbox cvsd2: Difference between revisions

Jump to navigation Jump to search
VisualWikitext
 
Line 14: Line 14:


==Overview==
==Overview==
<ref name="pmid24732918">{{cite journal| author=Hizoh I, Majoros Z, Major L, Gulyas Z, Szabo G, Kerecsen G et al.| title=Need for prophylactic application of verapamil in transradial coronary procedures: a randomized trial. The VITRIOL (is Verapamil In TransRadial Interventions OmittabLe?) trial. | journal=J Am Heart Assoc | year= 2014 | volume= 3 | issue= 2 | pages= e000588 | pmid=24732918 | doi=10.1161/JAHA.113.000588 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=24732918  }} </ref>


==Category==
==Category==

Latest revision as of 15:56, 21 August 2014



Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Ahmed Zaghw, M.D. [2]

For patient information, click here. Synonyms / Brand Names:




Overview

Category

FDA Package Insert

Indications and Usage | Dosage and Administration | Dosage Forms and Strengths | Contraindications | Warnings and Precautions | Adverse Reactions | Drug Interactions | Use in Specific Populations | Overdosage | Description | Clinical Pharmacology | Nonclinical Toxicology | Clinical Studies | How Supplied/Storage and Handling | Patient Counseling Information | Labels and Packages

Mechanism of Action

References

Retrieved from "https://www.wikidoc.org/index.php?title=Sandbox_cvsd2&oldid=1011221"